| Identification | Back Directory | [Name]
1H-Pyrazolo[4,3-d]pyriMidine, 5-chloro- | [CAS]
633328-98-0 | [Synonyms]
5-Chloropyrazolo[4,3-d]pyrimidine
5-CHLORO-1H-PYRAZOLO[4,3-D]PYRIMIDINE
1H-Pyrazolo[4,3-d]pyriMidine, 5-chloro- | [Molecular Formula]
C5H3ClN4 | [MDL Number]
MFCD18251003 | [MOL File]
633328-98-0.mol | [Molecular Weight]
154.56 |
| Chemical Properties | Back Directory | [density ]
1.653±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,2-8°C | [form ]
solid | [pka]
6.68±0.50(Predicted) | [color ]
Yellow | [InChI]
InChI=1S/C5H3ClN4/c6-5-7-1-4-3(9-5)2-8-10-4/h1-2H,(H,8,10) | [InChIKey]
MRTKTXTWOUDUTL-UHFFFAOYSA-N | [SMILES]
C1(Cl)=NC=C2NN=CC2=N1 |
| Hazard Information | Back Directory | [Uses]
5-Chloro-1H-pyrazolo[4,3-D]pyrimidine is used in preparation of pyrimidine derivatives and related heterocycles as DNA-dependent protein kinase inhibitors for treatment of diseases. | [Synthesis]
General procedure for the synthesis of 5-chloro-1H-pyrazolo[4,3-d]pyrimidin-1-yl from 1-(5-chloro-1H-pyrazolo[4,3-d]pyrimidin-1-yl)ethanone: To a stirred solution of 1-(5-chloro-1H-pyrazolo[4,3-d]pyrimidin-1-yl)ethanone (1.5 g, 7.65 mmol) in tetrahydrofuran (THF, 15 mL), was added an 8% hydrochloric acid aqueous solution (14.46 mL). The reaction mixture was refluxed at 50 °C for 30 min. After completion of the reaction, it was cooled to 25 °C and extracted with ethyl acetate (EtOAc, 2 × 50 mL). The organic layers were combined, dried over anhydrous sodium sulfate (Na2SO4), filtered and concentrated under reduced pressure to afford 5-chloro-1H-pyrazolo[4,3-d]pyrimidine as an off-white solid (1.1 g, 93% yield). Mass spectrum (ESI): m/z = 153.0 [M-H]-. | [References]
[1] Patent: WO2017/137334, 2017, A1. Location in patent: Page/Page column 123; 124
[2] Patent: CN105906621, 2016, A. Location in patent: Paragraph 0035
[3] Patent: US2012/202785, 2012, A1. Location in patent: Page/Page column 263 |
|
|